PharmaRadar360

PharmaRadar360

🇺🇸·4d agoRegulatory

Spinal Cord Stimulator Recall: Boston Scientific Removes Infinion CX Lead

Infinion CX Lead bodies may experience mechanical stress at the anchor site resulting in inadequate...

Publisher

F
FDA MedWatch

USA

This page provides a limited summary, publisher metadata, and related coverage to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
FDA MedWatch
Region
USA
Scope
Regulatory
Published
September 3, 2026
Language
EN

Publisher context, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Summary excerpt

Infinion CX Lead bodies may experience mechanical stress at the anchor site resulting in inadequate...

Source route

Continue on fda.gov

Leave the platform to read the original full article on the publisher site.

Source: FDA MedWatch

Scope: Regulatory

Open original article